Historical perspectives: Drug interactions - it all began with cheese

Journal of Internal Medicine

Volumn 268, Issue 6, 2010, Pages 512-515

  Sjoqvist F ^a   Bottiger Y ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Drug resistance; Drug therapy; Drugs

Indexed keywords

ANTIDIABETIC AGENT; BARBITURIC ACID DERIVATIVE; BILIRUBIN; CYCLOSPORIN; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DIGOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERICUM EXTRACT; INSECTICIDE; MONOAMINE OXIDASE INHIBITOR; NIALAMIDE; NORTRIPTYLINE; PHENOBARBITAL; QUINIDINE; SULFAPHENAZOLE; TOLBUTAMIDE;

ARTICLE; CHEESE; DEPRESSION; DIABETES MELLITUS; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG INDUSTRY; DRUG INTERACTION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; ENVIRONMENTAL EXPOSURE; ENZYME INDUCTION; FOOD DRUG INTERACTION; GENOTYPE; GLUCURONIDATION; HERBAL MEDICINE; HISTORY OF MEDICINE; HUMAN; HYPERLIPIDEMIA; HYPERTENSIVE CRISIS; HYPOGLYCEMIA; MEDICAL RESEARCH; MYOPATHY; NEWBORN JAUNDICE; NONHUMAN; OCCUPATIONAL EXPOSURE; PHARMACOGENETICS; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TRADITIONAL MEDICINE; TWINS;

BIOMEDICAL RESEARCH; CHEESE; DRUG INTERACTIONS; DRUG THERAPY; FOOD-DRUG INTERACTIONS; HISTORY, 20TH CENTURY; HUMANS;

EID: 78649458772     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02300.x     Document Type: Article

References (18)

1. Blackwell B. Hypertensive crises due to monoamine-oxidase inhibitors. Lancet 1963; 2: 849-50.
2. Natoff IL. Cheese and monoamine oxidase inhibitors. Interaction in Anaesthetised cats. Lancet 1964; 1: 532-3.
3. Horwitz D, Lovenberg W, Engelman K, Sjoerdsma A. Monoamine oxidase inhibitors, tyramine, and cheese. JAMA 1964; 188: 1108-10.
4. Hammer W, Holmberg G, Sjöqvist F, Wicklund PE. Drug interaction: lethal interaction between nialamide and blue-veined cheese. Lakartidningen 1969; 66(Suppl IV): 20.
5. Sjöqvist F. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances [Pharmaceutical Specialities in Sweden]. Proc R Soc Med 1965; 58: 967-78.
6. Alexanderson B, Sjöqvist F. Läkemedelsinteraktion. In FASS, 1970; 691-712.
7. Burns JJ, Conney AH. Enzyme stimulation and inhibition in the metabolism of drugs. Proc R Soc Med 1965; 58: 955-60.
8. Kolmodin B, Azarnoff DL, Sjöqvist F. Effect of environmental factors on drug metabolism: decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides. Clin Pharmacol Ther 1969; 10: 638-42.
9. Christensen LK, Hansen JM, Kristens M. Sulphaphenazole-induced hypoglycaemic attacks in tolbutamide-treated diabetics. Lancet 1963; 2: 1298-301.
10. Baldwin SJ, Bloomer JC, Smith GJ, Ayrton AD, Clarke SE, Chenery RJ. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 1995; 25: 261-70.
11. Alexanderson B, Price Evans DA, Sjöqvist F. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. BMJ 1969; 4: 764-8.
12. Steiner E, Dumont E, Spina E, Dahlqvist R. Inhibition of desipramine 2-hydroxylation by quinidine and quinine. Clin Pharmacol Ther 1988; 43: 577-81.
13. Ejvinsson G. Effect of quinidine on plasma concentrations of digoxin. BMJ 1978; 1: 279-80.
14. Angelin B, Arvidsson A, Dahlqvist R, Hedman A, Schenck-Gustafsson K. Quinidine reduces biliary clearance of digoxin in man. Eur J Clin Invest 1987; 17: 262-5.
15. Hedman A, Angelin B, Arvidsson A, Dahlqvist R, Nilsson B. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine. Clin Pharmacol Ther 1990; 47: 20-6.
16. Kalliokoski A, Niemi M. Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 2009; 158: 693-705.
17. Sjöqvist F. A new classification system for drug interactions. Eur J Clin Pharmacol 1997; 52(Suppl): 327a.
18. Böttiger Y, Laine K, Andersson M et al. SFINX - a drug-drug-interaction database designed for clinical decision support systems. Eur J Clin Pharmacol 2009; 65: 627-33.